Ofloxacin, Clotrimazole, Beclomethasone and Lignocaine Ear Drop

Available Composition of

Ofloxacin, Clotrimazole, Beclomethasone and Lignocaine Ear Drop
NameStrengthTherapeutic useView More
Ofloxacin Ornidazole Terbinafine and Clobetasol Cream0.75 % w/w + 2 % w/w + 1 % w/w + 0.05 % w/w, ,
Ofloxacin, Clotrimazole, Beclomethasone and Lignocaine Ear Drop0.3 % w/v + 1 % w/v + 0.025 % w/v + 2 % w/v
Ofloxacin Tablet200 mg, 400 mg
Ofloxacin Suspension50 mg
Ofloxacin Infusion200 mg / 100 ml
Ofloxacin Eye / Ear Drop0.3 % w/v
Ofloxacin and Ornidazole Tablet200 mg + 500 mg, , ,
Ofloxacin and Ornidazole Oral Suspension50 mg / 5 ml + 125 mg / 5 ml
Ofloxacin and Metronidazole Suspension100 mg/5 ml + 200 mg/5 ml, 50 mg/5 ml + 100 mg/5 ml
Ofloxacin and Ketorolac Eye Drop0.3 % w/v + 0.5 % w/v
Ofloxacin and Dexamethasone Eye Drop0.3 % w/v + 0.1 % w/v, ,
Lignocaine and Adrenaline Dental Cartridge2 % + 1:80000
Neomycin, Beclomethasone, Clotrimazole and Lignocaine Ear Drop5% w/v + 0.025% w/v + 1% w/v + 2% w/v, ,
Nitazoxanide and Ofloxacin Tablet500 mg + 200 mg, ,
Beclomethasone Injection100 mg, ,
Clotrimazole and Beclomethasone Cream1% w/w + 0.025% w/w,

Product Description For Ofloxacin, Clotrimazole, Beclomethasone and Lignocaine Ear Drop

products details and uses

Ofloxacin Clotrimazole Beclomethasone and Lignocaine Ear Drop Exporter, Manufacturer and Global Supplier

Ofloxacin Clotrimazole Beclomethasone and Lignocaine Ear Drop Exporter, choosing a reliable Ofloxacin Clotrimazole Beclomethasone and Lignocaine Ear Drop Exporter is extremely important for healthcare distributors, hospitals, and procurement agencies seeking consistent, high-quality supply. Ofloxacin, Clotrimazole, Beclomethasone and Lignocaine Ear Drop is a powerful multi-action otic formulation used for the treatment of mixed bacterial and fungal ear infections. This combination medication is widely recommended when patients present symptoms such as ear pain, itching, swelling, discharge, redness, or inflammation. Because of its exceptional efficacy, long shelf stability, and broad clinical application, the product is in high demand across domestic and global pharmaceutical markets.

The formulation contains four active ingredients, each addressing a specific aspect of ear infection. Ofloxacin is a potent fluoroquinolone antibiotic that targets harmful bacteria by inhibiting DNA replication. Clotrimazole is a proven antifungal agent effective against fungal species commonly responsible for otomycosis. Beclomethasone is a corticosteroid that reduces inflammation, swelling, and redness inside the ear canal. Lignocaine provides rapid local anaesthetic action, offering quick relief from pain and discomfort. Together, these ingredients ensure rapid recovery, symptom control, and prevention of secondary complications.

A professional Ofloxacin Clotrimazole Beclomethasone and Lignocaine Ear Drop Exporter ensures that the product adheres to stringent GMP and WHO-GMP manufacturing norms, guaranteeing purity, optimal potency, and safety across every batch.

Uses of Ofloxacin Clotrimazole Beclomethasone and Lignocaine Ear Drop

This combination ear drop is used for:

  • Acute and chronic otitis externa

  • Fungal ear infections such as otomycosis

  • Bacterial ear infections caused by susceptible organisms

  • Ear canal inflammation and swelling

  • Painful ear conditions due to infection

  • Mixed bacterial and fungal infections

  • Prevention of complications after ear procedures when recommended by a physician

Its broad antibacterial, antifungal, anti-inflammatory, and analgesic action makes it a preferred choice among ENT specialists and general physicians. Sourcing from a certified Ofloxacin Clotrimazole Beclomethasone and Lignocaine Ear Drop Exporter ensures consistent supply and quality for healthcare providers.

Precautions While Using the Ear Drop

Patients must use this ear drop exactly as directed by their healthcare provider. It is essential to warm the dropper slightly before use for comfort. The dropper must not touch the ear surface to avoid contamination. Patients with a history of perforated eardrum, chronic ear discharge, hypersensitivity to any component, or frequent ear infections should consult a doctor prior to use. Overuse or prolonged use may result in fungal overgrowth or antibiotic resistance. Pregnant and breastfeeding women should use this medication only if medically advised.

Healthcare institutions sourcing the product from an experienced Ofloxacin Clotrimazole Beclomethasone and Lignocaine Ear Drop Exporter benefit from clear labeling, regulatory compliance, and quality assurance documentation.

Possible Side Effects

Although generally safe, some patients may experience:

  • Mild burning or stinging sensation after application

  • Temporary itching or irritation

  • Dryness or redness in the ear canal

  • Rare allergic reactions such as rash or swelling

  • Imbalance or dizziness (very rare)

If symptoms worsen or persist, medical attention should be sought immediately. Reliable sourcing from a qualified Ofloxacin Clotrimazole Beclomethasone and Lignocaine Ear Drop Exporter helps reduce risks associated with substandard formulations or contaminated products.

Conclusion

Ofloxacin, Clotrimazole, Beclomethasone and Lignocaine Ear Drop stands as a complete therapeutic solution for multi-origin ear infections requiring antibacterial, antifungal, anti-inflammatory, and pain-relieving action. Its four-component formulation ensures faster recovery, symptom control, and improved patient comfort. For pharmaceutical distributors, hospitals, government tenders, and international importers, partnering with a trusted Ofloxacin Clotrimazole Beclomethasone and Lignocaine Ear Drop Exporter ensures access to premium-quality otic formulations that meet global regulatory and quality standards.

 

Global Distribution Network

With a strong logistics and compliance framework, we successfully export Ofloxacin Clotrimazole Beclomethasone and Lignocaine Ear Drop to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.